Blood chemicals study in lung scarring and high lung blood pressure
Part of Lungs & breathing clinical trials.
This study looks at special chemicals in the blood (metabolites) from people with both lung scarring and high lung blood pressure. It aims to learn how these chemicals change with or without treatment for the lung blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a worsening type of lung scarring called interstitial lung disease (ILD), like pulmonary fibrosis.
- Your doctor suspects you have high blood pressure in the lungs (pulmonary hypertension) caused by your lung disease.
- You are scheduled to have a heart catheterization (a thin tube test) to confirm the diagnosis.
- You have agreed to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to track lung scarring (fibrosis) over time in people with conditions like IPF, other fibrotic lung diseases, or early signs of scarring. It might help doctors understand how the disease changes.
This study follows people who are being seen for lung scarring (also called ILD) and compares them with family members without lung scarring. It helps researchers better understand how this condition changes over time and what to look for in the future.
This study builds a “biobank,” a storage of blood and related samples, from people with lung interstitial lung diseases or other lung scarring diseases. Your samples help researchers study these conditions and improve future care.
This study looks at patterns from specialized lung scan tests to help diagnose chronic thromboembolic pulmonary hypertension (a long-term problem with blood flow in the lungs after blood clots). If your results suggest this condition and you need a procedure to check heart pressure, you may be asked to join so the researchers can improve diagnosis.
This trial tests a new medicine called TX000045 for people who have both lung scarring (interstitial lung disease) and high blood pressure in the lungs (pulmonary hypertension). It aims to see if the drug can help improve breathing and daily function.
This study looks at lung tissue from people having chest surgery to understand why some lung diseases lead to high blood pressure in the lungs (pulmonary hypertension). You may be eligible if you're having lung surgery or are on the lung transplant list.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.